HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A–cyclophilin A interaction to cyclophilin inhibitors

This publication has 30 references indexed in Scilit:

• SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA Replication In Vitro
  Antimicrobial Agents and Chemotherapy, 2010
• Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics
  PLoS Pathogens, 2009
• Critical Role of Cyclophilin A and Its Prolyl-Peptidyl Isomerase Activity in the Structure and Function of the Hepatitis C Virus Replication Complex
  Journal of Virology, 2009
• The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication
  Journal of Biological Chemistry, 2009
• Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B
  Journal of Biological Chemistry, 2009
• Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors
  Antimicrobial Agents and Chemotherapy, 2009
• Combinations of Cyclophilin Inhibitor NIM811 with Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of Resistance
  Antimicrobial Agents and Chemotherapy, 2008
• Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro
  Journal of Virology, 2008
• NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon
  Antimicrobial Agents and Chemotherapy, 2006
• Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication
  Journal of Virology, 2006